321 related articles for article (PubMed ID: 17699375)
1. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?
Kalantar-Zadeh K; Kalantar-Zadeh K; Lee GH
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S9-18. PubMed ID: 17699375
[TBL] [Abstract][Full Text] [Related]
2. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
Dukkipati R; Kalantar-Zadeh K
Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
[TBL] [Abstract][Full Text] [Related]
3. Assessing iron status: beyond serum ferritin and transferrin saturation.
Wish JB
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
[TBL] [Abstract][Full Text] [Related]
5. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
Easom A
Nephrol Nurs J; 2006; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
[TBL] [Abstract][Full Text] [Related]
6. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
7. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
8. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
[TBL] [Abstract][Full Text] [Related]
9. Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients.
Kovesdy CP
Adv Chronic Kidney Dis; 2009 Mar; 16(2):109-16. PubMed ID: 19233070
[TBL] [Abstract][Full Text] [Related]
10. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
Fishbane S
Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518
[TBL] [Abstract][Full Text] [Related]
11. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
Ueda N; Takasawa K
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive vision for intravenous iron therapy.
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
Ferrari P; Mallon D; Trinder D; Olynyk JK
Nephrology (Carlton); 2010 Apr; 15(3):344-9. PubMed ID: 20470305
[TBL] [Abstract][Full Text] [Related]
14. [How do we optimally evaluate iron stores in dialyzed patients treated with erythropoiesis stimulating agent?].
Kessler M; Salignac S; Aimone-Gastin I
Nephrol Ther; 2006 Sep; 2 Suppl 4():S261-5. PubMed ID: 17373268
[TBL] [Abstract][Full Text] [Related]
15. Iron therapy in chronic kidney disease: current controversies.
Kovesdy CP; Kalantar-Zadeh K
J Ren Care; 2009 Dec; 35 Suppl 2():14-24. PubMed ID: 19891681
[TBL] [Abstract][Full Text] [Related]
16. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.
Fishbane S; Pollack S; Feldman HI; Joffe MM
Clin J Am Soc Nephrol; 2009 Jan; 4(1):57-61. PubMed ID: 18987297
[TBL] [Abstract][Full Text] [Related]
17. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
18. IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.
Larson K
Nephrol Nurs J; 2008; 35(2):184-93; quiz 194-5. PubMed ID: 18472686
[TBL] [Abstract][Full Text] [Related]
19. Importance of ferritin for optimizing anemia therapy in chronic kidney disease.
Nakanishi T; Kuragano T; Nanami M; Otaki Y; Nonoguchi H; Hasuike Y
Am J Nephrol; 2010; 32(5):439-46. PubMed ID: 20881381
[TBL] [Abstract][Full Text] [Related]
20. Evaluating traditional iron measures and exploring new options for patients on hemodialysis.
Petroff S
Nephrol Nurs J; 2005; 32(1):65-73; quiz 74-5. PubMed ID: 15787086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
